Sitagliptin in Non-Diabetic Patients Undergoing General Surgery

NCT02741687 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Hyperglycemia

Interventions

DRUG: Sitagliptin
DRUG: Placebo
DRUG: Supplemental insulin (insulin lispro)
DRUG: Supplemental insulin (insulin aspart)
DRUG: Long acting basal insulin (insulin detemir)
DRUG: Long acting basal insulin (insulin glargine)

Sponsor

Emory University